Hepatitis B vaccination strategies may vary from country to country de
pending on hepatitis B virus (HBV) endemicity, predominant modes of in
fection, age of infection, and health care resources. In areas with hi
gh endemicity like Korea, transmission of virus from carrier mothers t
o infants during the perinatal period, and from other horizontal sourc
es to infants and children, account for most cases of HBV infection. T
he consequences of HBV infection at an early age are serious, as more
than 70% remain chronic carriers of the virus. These chronic carriers
are the principal source of infection for other susceptible people, an
d are themselves at high risk of developing other serious diseases, su
ch as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
. Theoretically, therefore, routine infant immunisation supplemented w
ith prenatal screening of pregnant women for HBsAg or HBeAg and mass i
mmunisation of children is the appropriate strategy for control of hep
atitis B in these countries. To prevent primary liver cancer associate
d with HBV infection, however, immunisation of adults at high risk wou
ld also be prudent. Mandatory vaccination of all neonates is recommend
ed in highly endemic areas, together with hepatitis B immune globulin
in babies born to HBsAg carrier mothers.